CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
  • Home
    • About
      • Message from the Editor-in-Chief
      • Mission Statement
      • Editorial Board
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
Search
  • Home
    • About
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
Follow US
Cardiovascular SurgeryUncategorized

Saphenous Vein Graft Harvesting for CABG: Endoscopic Vs Open Technique

Ahmed Younes, M.D.
Share
4 Min Read

A new study published in the New England Journal of Medicine showed no significant difference in the risk of major adverse cardiac events (MACE) between patients undergoing endoscopic and open harvest of the saphenous vein grafts for coronary artery bypass grafting (CABG).

Contents
  • Are the two techniques really different?
  • The role of surgeon expertise

Are the two techniques really different?

A total of 1150 patients from 16 veterans affairs cardiac surgery centers were randomized to either undergoing open or endoscopic saphenous vein-graft harvesting. The primary outcome was a MACE composite (death from any cause, nonfatal myocardial infarction, and repeat revascularization). MACE occurred in 15.5% of the open-harvest group of patients and 13.9% of the endoscopic-harvest group (HR 1.12; 95% confidence interval [CI] 0.83 to 1.51; P = 0.47). Death from any cause occurred in 8% of the open-harvest group and 6.4% of the endoscopic-harvest group (HR 1.25; 95% CI 0.81 to 1.92). Myocardial infarction occurred in 5.9% of the open-harvest group and 4.7% of the endoscopic-harvest group (HR 1.27; 95% CI 0.77 to 2.11).

[perfectpullquote align=”full” bordertop=”false” cite=”” link=”” color=”” class=”” size=””]“I believe that one of the conclusions is that in an expert’s hand, an endoscopic harvest is probably the preferred approach in 2018. Now, we are moving to the use of multiple arterial conduits but it is unlikely that we are going to shelf vein graft. It will always be part of the mixture.” -Dr. Marco Zenati, M.D.[/perfectpullquote]

The study also looked into the incidence of leg-wound infections. This complication occurred in 3.1% of the open-harvest group and 1.4% of the endoscopic-harvest group (RR 2.26; 95% CI 0.99 to 5.15) with no significant difference between the two groups. Dr. Marco Zenati (VA Boston Healthcare System) commented, “The major limitation of the study published in 2009 was that they had no information about who harvested the veins. That’s very important because there’s a steep learning curve to do an endoscopic harvest.”

The role of surgeon expertise

Saphenous vein grafts are the most commonly used conduits for CABG with the high rates of graft failure and the harvest site complications being the major adverse outcomes for this procedure. In the US, most of the saphenous vein grafts are harvested using the endoscopic vein-graft harvesting technique. However, the patency of the grafts harvested using this technique was consistently lower than grafts harvested using nonendoscopic techniques in previous data. This is possibly due to the overstretch injury occurring due to endoscopic harvesting when the procedure is performed by inexperienced surgeons.

The trial design required a high degree of expertise in the surgeons as inexperienced surgeons can cause unnecessary stretching of the vein during harvesting. The authors identified some limitations of the study such as the absence of imaging evaluation of the graft patency, the focus on experienced harvesters. Also in the open-harvest group, all the procedures were performed using the traditional open harvesting technique without using the open ‘no-touch’ technique. Dr. Zenati concluded, “I believe that one of the conclusions is that in an expert’s hand, an endoscopic harvest is probably the preferred approach in 2018. Now, we are moving to the use of multiple arterial conduits but it is unlikely that we are going to shelf vein graft. It will always be part of the mixture.”

TAGGED:AHA 2018FeaturedNews
Share This Article
Copy Link Print
ByAhmed Younes, M.D.
Follow:
Hello test here.
Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

CardiologyNowNews.org CardiologyNowNews.org
Copyright - CardiologyNowNews
  • Contact Us
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?